Lenrispodun

lenrispodun · Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenrispodun, covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease [Phase 2]

See pricing